KerenZhouMD

Endocrinology • Cleveland, OH

Diabetes, Lipid Metabolism

Cleveland Clinic Department of Endocrinology

Join to view full profile

Dr. Zhou is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Zhou's full profile

Already have an account?

Office
9500 Euclid Ave
Cleveland, OH 44195
Phone+1 216-444-2200

Fax+1 216-445-6290

Education & Training

Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2019
Cleveland Clinic FoundationResidency, Internal Medicine, 2014 - 2017
Case Western Reserve University School of MedicineClass of 2014

Certifications & Licensure

OH State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Publications & Presentations

PubMed

De-intensification of basal-bolus therapy by replacing prandial insulin with once-weekly subcutaneous semaglutide in individuals with well-controlled type 2 diabetes: ...
Paloma Rodriguez, Nikki Breslaw, Huijun Xiao, Jim Bena, Kimberly Jenkins
Diabetes, Obesity & Metabolism. 2025-02-01
Preoperative and Postoperative Predictors of Insulin Independence From Total Pancreatectomy and Islet Autotransplantation.
Eliot N Haddad, M Cecilia Lansang, Huijun Xiao, R Matthew Walsh, Robert Simon
Endocrine Practice. 2024-08-01
Surgical versus medical management of patients with primary hyperaldosteronism and indeterminate adrenal vein sampling: A 10-year experience of the Cleveland Clinic.
Chineme Onwubueke, Saif M Borgan, Huijun Xiao, Keren Zhou
Journal of Clinical Hypertension. 2024-05-01

Lectures

Non-Neoplastic Thyroid
ENDO 2019 - New Orleans, LA - 3/25/2019

Press Mentions

Oncology Pharmacovigilance Clinic Expands SpecialtiesMay 2nd, 2024
Pioglitazone Use May Help Reduce Dementia Risk in People with Type 2 Diabetes, Claims New StudyFebruary 22nd, 2023
Older Diabetes Medication Linked to Lower Dementia RiskFebruary 16th, 2023